コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 or necrosis factor alpha and lower levels of insulin-like growth factor 2.
2 he growth-promoting and mitogenic effects of insulin-like growth factor 2.
3 3 as a dominant driver oncogene at the IGF2 (insulin-like growth factor-2) 11p15.5 CRC amplicon, indu
6 he increased expression of transthyretin and insulin-like growth factor-2 and the increased phosphory
7 redictions for three case studies on leptin, insulin-like-growth-factor 2 and the inhibitor of NF-kap
8 rol region (ICR) of the genes Igf2 (encoding insulin-like growth factor 2) and H19 (fetal liver mRNA)
9 of the most studied imprinted genes encodes insulin-like growth factor 2, and aberrant imprinting an
10 iation [RalGDS/AF-6] domain family member 1, insulin-like growth factor 2, and adenomatous polyposis
12 ch as insulin, insulin-like growth factor 1, insulin-like growth factor 2, and phosphatidylcholine-sp
13 ent is found in the regulatory region of the insulin-like growth factor 2, angiotensin-converting enz
14 ontains the {tyrosine hydroxylase (TH)-(INS)-insulin-like growth factor 2 antisense (IGF2AS)-insulin-
15 endent kinase inhibitor protein 2) and Igf2 (insulin-like growth factor 2) are induced by inhibiting
16 r beta1, vascular endothelial growth factor, insulin-like growth factor 2) but not others (platelet-d
19 t-of-origin-specific expression of the mouse insulin-like growth factor 2 gene (Igf2) and the closely
25 roximately 10,000 human genes, we identified insulin-like growth factor 2 (IGF-2) as a potentially im
27 periments showed that, among other proteins, insulin-like growth factor 2 (IGF-2) is specifically exp
28 tem cell factor (SCF), thrombopoietin (TPO), insulin-like growth factor 2 (IGF-2), and fibroblast gro
30 The activity of the exogenous, full-length insulin-like growth factor-2 (IGF-2) P3 promoter is sign
36 ntially methylated regions (DMRs) regulating Insulin-like Growth Factor 2 (IGF2) and H19, and how thi
38 IGF2 and IGF2R code for the growth promoter insulin-like growth factor 2 (IGF2) and its inhibitor, m
39 ions in the transportation and regulation of insulin-like growth factor 2 (IGF2) and mannose 6-phosph
40 ing and in situ hybridization, we identified insulin-like growth factor 2 (IGF2) as a marker for a su
41 mitosis with un-repaired DNA through driving insulin-like growth factor 2 (IGF2) expression and Akt a
42 mouse hippocampus, induces the expression of insulin-like growth factor 2 (IGF2) for the stabilizatio
43 usly demonstrated an association between the insulin-like growth factor 2 (IGF2) gene 3'-untranslated
44 t-of-origin-specific expression of the mouse insulin-like growth factor 2 (Igf2) gene and the closely
47 the otherwise repressed maternal copy of the insulin-like growth factor 2 (IGF2) gene is expressed, l
49 s Network detected the overexpression of the insulin-like growth factor 2 (IGF2) gene, encoding a lig
60 reviously shown that the loss of function of insulin-like growth factor 2 (igf2) suppresses MB format
61 t that Hh markedly induces the expression of insulin-like growth factor 2 (Igf2) that activates the m
63 oss of imprinting (LOI) in key genes such as insulin-like growth factor 2 (IGF2) which often results
66 suggest that glypican 3 forms a complex with insulin-like growth factor 2 (IGF2), and might thereby m
67 d genes: paternally expressed gene 3 (PEG3), insulin-like growth factor 2 (IGF2), and small nuclear r
68 activating enzyme, deiodinase-III (Dio3) and insulin-like growth factor 2 (Igf2), genes that are know
69 ma (HCC) biomarkers alpha-fetoprotein (Afp), insulin-like growth factor 2 (Igf2), H19, and glypican-3
71 he expression of several myokines, including insulin-like growth factor 2 (IGF2), whereas RNAi and do
72 Expression of the imprinted genes H19 and insulin-like growth factor 2 (Igf2), which lie in close
73 the expression of multiple genes, including insulin-like growth factor 2 (Igf2), whose expression is
77 bridization, we found that one allele of the insulin-like growth factor 2 (Igf2)/H19 imprinting contr
78 ulin-like growth factor 2 antisense (IGF2AS)-insulin-like growth factor 2 (IGF2)} gene cluster, unusu
79 e of the imprinted embryonic gene coding for insulin-like growth factor 2 (IGF2, Igf2(+m/-p)), result
82 (Mob1), adult obesity and diabetes (Ad), and insulin-like growth factor-2 (Igf2), map to murine regio
85 ts known ability to promote the abundance of Insulin-like Growth Factor 2/IGF2, we find that IMP2 str
87 factor-2 transcripts, and therefore null for insulin-like growth factor-2 in both placenta and foetus
88 2; the guanine nucleotide exchanger RasGRP2, insulin-like growth factor-2, integrin beta 4), cell mig
89 alpha-driven expression of transthyretin and insulin-like growth factor 2 is necessary for protection
91 e is 500 kb centromeric to the gene encoding insulin-like growth factor 2, it is likely to be part of
93 We focused our subsequent analyses on the Insulin-like growth factor 2 messenger RNA (mRNA)-bindin
94 C differentiation) and the downregulation of insulin-like growth factor 2 mRNA (promoter of OPC diffe
96 f the heterochronic let-7 miRNA pathway, the insulin-like growth factor 2 mRNA-binding protein 1 (IGF
102 emand and placental supply of nutrients (the insulin-like growth factor-2-P0 KO) and one where demand
103 ull for the placenta-specific P0 transcript (insulin-like growth factor-2-P0 KO) to mice with disrupt
104 ha-spectrin, 2,3-bisphosphoglycerate mutase, insulin-like growth factor-2, porphobilinogen deaminase
105 The cation independent mannose 6-phosphate/insulin-like growth factor 2 receptor (IGF2R) functions
106 ependent kinase inhibitor 1C (Cdkn1c) or the insulin-like growth factor 2 receptor (Igf2r) leads to f
108 bors positional candidate genes, such as the insulin-like growth factor 2 receptor (IGF2R, 6q26) and
109 g binding molecules, the mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P-IGF2R, CD222)
110 labeled CTGF and soluble mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF-2-R) alon
113 own that inactivation of mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) is a c
115 s the cation-independent mannose 6-phosphate/insulin-like growth factor 2 receptor, is the central co
116 acellular domains of the mannose 6-phosphate/insulin-like growth factor-2 receptor (M6P/IGF2R), domai
117 a(-/-) tumors showed increased expression of insulin-like growth factor 2, retinoblastoma protein, an
118 nhancement was mediated by a soluble factor (insulin-like growth factor 2) secreted by monocytes.
121 pression of maternal and paternal alleles of insulin-like growth factor 2 switched to predominant exp
122 Ins-2 (encodes insulin-2) and Igf-2 (encodes insulin-like growth factor-2), that lie 90 and 115 kb 5'
123 correlated with activation of 3 promoters of insulin-like growth factor 2; these processes appeared t
127 -P0 KO) to mice with disruptions of all four insulin-like growth factor-2 transcripts, and therefore
128 xpression of the trophoblast survival factor insulin-like growth factor-2 was significantly lower.
129 wth factor-alpha, preadipocyte factor-1, and insulin-like growth factor-2 were key genes differential
130 enes in the insulin-signaling pathway, e.g., insulin-like growth factor-2, were increased selectively
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。